1089 related articles for article (PubMed ID: 22393530)
21. The Complex Role of Apolipoprotein E in Alzheimer's Disease: an Overview and Update.
Mahoney-Sanchez L; Belaidi AA; Bush AI; Ayton S
J Mol Neurosci; 2016 Nov; 60(3):325-335. PubMed ID: 27647307
[TBL] [Abstract][Full Text] [Related]
22. Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease.
Martiskainen H; Haapasalo A; Kurkinen KM; Pihlajamäki J; Soininen H; Hiltunen M
Expert Opin Ther Targets; 2013 Jul; 17(7):781-94. PubMed ID: 23573918
[TBL] [Abstract][Full Text] [Related]
23. High-density lipoprotein mimetic peptide 4F mitigates amyloid-β-induced inhibition of apolipoprotein E secretion and lipidation in primary astrocytes and microglia.
Chernick D; Ortiz-Valle S; Jeong A; Swaminathan SK; Kandimalla KK; Rebeck GW; Li L
J Neurochem; 2018 Dec; 147(5):647-662. PubMed ID: 30028014
[TBL] [Abstract][Full Text] [Related]
24. ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.
Manelli AM; Stine WB; Van Eldik LJ; LaDu MJ
J Mol Neurosci; 2004; 23(3):235-46. PubMed ID: 15181252
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex.
Arold S; Sullivan P; Bilousova T; Teng E; Miller CA; Poon WW; Vinters HV; Cornwell LB; Saing T; Cole GM; Gylys KH
Acta Neuropathol; 2012 Jan; 123(1):39-52. PubMed ID: 22020632
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-β.
Chai AB; Lam HHJ; Kockx M; Gelissen IC
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Sep; 1866(9):158980. PubMed ID: 34044125
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.
Butterfield DA; Mattson MP
Neurobiol Dis; 2020 May; 138():104795. PubMed ID: 32036033
[TBL] [Abstract][Full Text] [Related]
28. [Role of apolipoprotein E in the molecular pathomechanism of Alzheimer disease].
Michikawa M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2014 Feb; 34(1):5-9. PubMed ID: 25069266
[TBL] [Abstract][Full Text] [Related]
29. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
Fan J; Donkin J; Wellington C
Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E lipoprotein particles inhibit amyloid-β uptake through cell surface heparan sulphate proteoglycan.
Fu Y; Zhao J; Atagi Y; Nielsen HM; Liu CC; Zheng H; Shinohara M; Kanekiyo T; Bu G
Mol Neurodegener; 2016 May; 11(1):37. PubMed ID: 27151330
[TBL] [Abstract][Full Text] [Related]
31. Quercetin stabilizes apolipoprotein E and reduces brain Aβ levels in amyloid model mice.
Zhang X; Hu J; Zhong L; Wang N; Yang L; Liu CC; Li H; Wang X; Zhou Y; Zhang Y; Xu H; Bu G; Zhuang J
Neuropharmacology; 2016 Sep; 108():179-92. PubMed ID: 27114256
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy.
Bu G
Nat Rev Neurosci; 2009 May; 10(5):333-44. PubMed ID: 19339974
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
Donahue JE; Johanson CE
J Neuropathol Exp Neurol; 2008 Apr; 67(4):261-70. PubMed ID: 18379441
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies.
Yamazaki Y; Zhao N; Caulfield TR; Liu CC; Bu G
Nat Rev Neurol; 2019 Sep; 15(9):501-518. PubMed ID: 31367008
[TBL] [Abstract][Full Text] [Related]
36. Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43.
Wennberg AM; Tosakulwong N; Lesnick TG; Murray ME; Whitwell JL; Liesinger AM; Petrucelli L; Boeve BF; Parisi JE; Knopman DS; Petersen RC; Dickson DW; Josephs KA
JAMA Neurol; 2018 Nov; 75(11):1347-1354. PubMed ID: 30422173
[TBL] [Abstract][Full Text] [Related]
37. Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples.
Tai LM; Bilousova T; Jungbauer L; Roeske SK; Youmans KL; Yu C; Poon WW; Cornwell LB; Miller CA; Vinters HV; Van Eldik LJ; Fardo DW; Estus S; Bu G; Gylys KH; Ladu MJ
J Biol Chem; 2013 Feb; 288(8):5914-26. PubMed ID: 23293020
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E receptor pathways in Alzheimer disease.
Schmidt V; Carlo AS; Willnow TE
Wiley Interdiscip Rev Syst Biol Med; 2014; 6(3):255-70. PubMed ID: 24604742
[TBL] [Abstract][Full Text] [Related]
39. The interaction of amyloid-beta with ApoE.
Carter DB
Subcell Biochem; 2005; 38():255-72. PubMed ID: 15709483
[TBL] [Abstract][Full Text] [Related]
40. Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol.
Petanceska SS; DeRosa S; Sharma A; Diaz N; Duff K; Tint SG; Refolo LM; Pappolla M
J Mol Neurosci; 2003; 20(3):395-406. PubMed ID: 14501024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
